It is a very special honour for me to be able to present this handbook of medical oncology, which under diverse headings and origins covers such a vast spectrum of experience.
One reason for failure to cure solid tumors by surgery appears to be the impossibility of controlling metastases that are present but latent at the time of operation.
Malignant growth of cells is often characterized by disorganization of tissue structure, abnormal blood vessel development, and insuffi- cient vascular supply.
Predictive drug testing on human tumor cells in order to define the appropriate chemotherapy will remain imperative as long as the anticancer agents available are few in number and show only limited activity.
At first glance it appears that little has happened in our understanding of bronchogenic carcinoma, since five year survival rates have not changed appreciably over the past ten years.
This publication brings together a number of papers presented at the Fourth Symposium on Clinical Oncology held at the Royal College of Radiologists, London, in February 1982.
The enormous expansion seen over the last decade in the mammo- graphic detection of breast cancer lesions, especially the use of screen- ing procedures for the early detection of clinically unsuspected tumors, has made it necessary to summarize the experience made by various centers in the world.
Substantial relief of discomfort may be anticipated by most patients suffering from pelvic and lower-extremity pain who are treated by arterial infusion of nitrogen mustard.
Transplantation of syngeneic (donor is a monozygous twin) or allogeneic (donor is an HLA-identical sibling) marrow provides the opportunity for aggressive antileukemic therapy without regard to marrow toxicity.
Attempts to influence survival of patients with colorectal cancer (CRC) by adjuvant chemotherapy are limited by the variability of survival in different prognostic groups [4] and the paucity of drugs that have shown activity in the advanced disease [10].
Progress in basic research has made it necessary to redetermine the possibility of classic endocrine therapy for the treatment of patients with breast cancer.
The subject of this publication, thyroid cancer, was the topic chosen for the First Symposium on Clinical Oncology, orga- nized by the Royal College of Radiologists, London, on 26 and 27 January 1979.
We have studied 24 cases of secondarily leukemic (stage V) lymphosarcoma (LS), 31 cases of "e;d'emblee"e; leukemic LS, and ten cases of lymphoid leukemic neoplasias transitional between "e;d'emblee"e; leukemic LS and chronic lymphocytic leukemia (eLL).
The cloning of hemopoietic cells in semisolid medium began some 12 years ago, and when colonies of T = and B = lymphocytes were grown by several groups last year, the last major subclasses of hemopoietic cells had been successfully cultured in vitro.
Since the first observations of Busch in 1866, the possible use of heat as a therapeutic agent in the cure of cancer has been repeatedly subject to bursts of interest, almost invariably followed by periods of neglect and skepticism.
I would like to thank all my co-workers who have collaborated with me, from 1963 until now, in biological and clinical research in the field of cancer active immunotherapy, of its immuno- prevention and immunorestoration.